Intel’s Chip Business Shows Signs of Life After Years of Struggle
Intel's chip business is showing early signs of operational recovery after years of market share losses and manufacturing setbacks, with the company positioned as a centerpiece of U.S. onshoring policy. However, with near-zero net margins and a slight revenue decline, any turnaround thesis remains speculative and early-stage.
What happened
Intel's chip business is showing early signs of operational recovery after years of market share losses and manufacturing setbacks, with the company positioned as a centerpiece of U.S. onshoring policy.
The read · Jun 26
INTC is caught between a compelling U.S. onshoring political narrative and near-zero profitability — the question is whether the early operational signs translate into a real earnings inflection or remain a headline-driven story.
Wrong if
A delay or reduction in CHIPS Act disbursements, failure to win external IFS customers, or another process node execution miss would undercut both the political and fundamental cases simultaneously.
CoverageSource: NYT Business · Published here FRI, JUN 26 · 4:54 AM ET · the only report in this recordHow this is decided →
The chart · INTCTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
Intel's chip business is generating cautious optimism after a prolonged stretch of manufacturing delays, market share erosion against TSMC and AMD, and leadership turnover. The NYT piece frames Intel as the flagship of the Trump administration's push to reshore semiconductor production to the U.S., giving the stock a political tailwind that goes beyond pure fundamentals.
The enrichment data tells a more sobering story: FY2025 revenue of $52.9B is essentially flat year-over-year (-0.5%), gross margins sit at a modest 34.8%, and diluted EPS is barely negative at -$0.06 — meaning Intel is running at breakeven at best, with no real earnings engine yet rebuilt. Net margin is effectively zero. These are not the numbers of a confirmed turnaround; they are the numbers of a company that has stopped bleeding out.
The bull case rests on the CHIPS Act funding pipeline, Intel Foundry Services as a long-term revenue diversifier, and the idea that geopolitical tailwinds make Intel strategically untouchable. If IFS wins meaningful external customers and margins inflect upward, the operating leverage could be substantial given the fixed-cost nature of fabs.
The bear case is equally concrete: Intel is still losing ground in data center CPUs to AMD, has not proven it can manufacture at competitive nodes, and gross margins of 34.8% lag TSMC and Nvidia by a wide margin. Any slowdown in government support or a delay in next-gen process nodes could push the stock back toward cycle lows.
The honest read here is a genuinely two-sided setup — political and structural tailwinds versus weak near-term financials and competitive headwinds. The trade lacks a clear near-term catalyst date, making sizing and timeframe difficult to pin down.
The read, in fullWhy it matters
Intel's FY2025 financials show revenue nearly flat and EPS at -$0.06 with 34.8% gross margins — consistent with stabilization, not confirmed recovery. The Trump administration CHIPS Act narrative adds a non-fundamental bid, but without a clear earnings inflection catalyst or external IFS customer win, grounding a directional trade is difficult. The setup is genuinely two-sided and headline-driven rather than data-driven at this stage.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written · closes shown from JUN 26 on
Next · what would move this
Unclear — no near-term catalyst pinned. Follow to be told when one lands.
▲ The case it holds
If Intel Foundry Services secures meaningful external customers and next-gen node yields improve, the operating leverage on a largely fixed-cost fab base could drive a sharp margin inflection from the current 34.8% gross margin floor — a dynamic the market may not yet be pricing.
▼ The case it breaks
With diluted EPS at -$0.06, gross margins 20+ points below Nvidia and trailing AMD in data center CPU share, Intel's 'signs of life' remain fragile — any process node slip or government funding delay could re-test cycle lows with no earnings cushion to absorb the blow.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
Reaction = the first close after the story against the close before it. Prior-session closes only; not a call.
The memory
This page is kept as it was written on Jun 26. Later coverage joins it only when the company and catalyst evidence match, and what the stock did is shown from licensed end-of-day closes — never re-graded, never backdated. The judgment is yours.